SEC 13F Intelligence

Octagon Capital Advisors LP / COGT

Octagon Capital Advisors LP’s Cogent Biosciences Inc Position

Does Octagon Capital Advisors LP own Cogent Biosciences Inc (COGT)? Yes — 2.35M shares worth $90M (+10.01% of its 13F portfolio) as of Q1 2026.

Position Value
$90M
Q1 2026
Shares
2.35M
% of Portfolio
+10.01%
Quarters Held
7
currently held

Position History COGT

Reported value by quarter
Q3 ’24: $14MQ3 ’24Q4 ’24: $22MQ4 ’24Q1 ’25: $17MQ1 ’25Q2 ’25: $20MQ2 ’25Q3 ’25: $41MQ3 ’25Q4 ’25: $83MQ4 ’25Q1 ’26: $90MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.35M$90M+10.01%
Q4 20252.35M$83M+10.13%
Q3 20252.87M$41M+6.26%
Q2 20252.76M$20M+4.35%
Q1 20252.76M$17M+3.20%
Q4 20242.76M$22M+3.55%
Q3 20241.30M$14M+2.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of COGT.